Published in PLoS One on December 13, 2013
Inhibition of insulin/IGF-1 receptor signaling protects from mitochondria-mediated kidney failure. EMBO Mol Med (2015) 0.89
Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature (2010) 11.24
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) N Engl J Med (2000) 8.02
Cell biology of the glomerular podocyte. Physiol Rev (2003) 6.85
Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet (1993) 6.56
Aristolochic acid nephropathy: a worldwide problem. Kidney Int (2008) 2.73
Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci U S A (2007) 2.52
Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol (2008) 2.35
Signaling at the slit diaphragm. J Am Soc Nephrol (2004) 2.11
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis (2002) 1.90
Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens (2001) 1.54
Identification of aristolochic acid in Chinese herbs. Lancet (1994) 1.45
Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction? Mitochondrion (2012) 1.35
Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol (2002) 1.35
Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis (1994) 1.29
Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert. N Engl J Med (2003) 1.15
Acute nephrotoxicity of aristolochic acids in mice. J Pharm Pharmacol (2004) 1.12
WT1-dependent sulfatase expression maintains the normal glomerular filtration barrier. J Am Soc Nephrol (2011) 1.10
Etiology of Balkan endemic nephropathy and associated urothelial cancer. Am J Nephrol (2006) 1.10
Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer. Int J Cancer (2005) 1.08
A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. J Am Soc Nephrol (2002) 1.06
Quantitative analysis of aristolochic acids, toxic compounds, contained in some medicinal plants. J Ethnopharmacol (1999) 1.00
Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2. Chem Res Toxicol (2001) 0.97
Urothelial malignancy in nephropathy due to Chinese herbs. Lancet (1994) 0.94
Systemic administration of naked plasmid encoding HGF attenuates puromycin aminonucleoside-induced damage of murine glomerular podocytes. Am J Physiol Renal Physiol (2011) 0.93
Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology. Arch Toxicol (1993) 0.85
The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids. Kidney Int (2004) 0.83
Transgene-derived hepatocyte growth factor attenuates reactive renal fibrosis in aristolochic acid nephrotoxicity. Nephrol Dial Transplant (2003) 0.81
Aristolochia sp and chronic interstitial nephropathies in Indians. Lancet (1997) 0.79